Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site
ESSEN, Germany, July 8, 2026 /PRNewswire/ — Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company will invest
